Cardiff Lexington Corporation · OTC:CDIX

Cardiff Lexington — Q3 2026 Earnings Presentation

10 slides from Cardiff Lexington's earnings presentation, Nov 16, 2026

  1. Slide 1: Third Quarter 2026 Earnings Presentation

    THIRD QUARTER 2026 EARNINGS PRESENTATION Monday, November 16, 2026 OTC: CDIX

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS This presentation does not constitute or form part of and should not be construed as, an offer to sell or issue or the solici tation of an offer to buy or subscribe for securities of Cardiff Lexington (the “Company”) in any jurisdiction or an inducement to enter into inves

  3. Slide 3: Executive Summary: Cardiff Lexington by the Numbers

    EXECUTIVE SUMMARY Cardiff Lexington by the Numbers YTD ended September 30, 2026 Operational & Strategic Updates 11 Nova Ortho and Spine locations • Continued strong demand for throughout Florida & Georgia healthcare services $6.3 M • Announced letter of intent for proposed acquisition of leading YTD

  4. Slide 4: Letter of Intent for Proposed Acquisition of Leading Healthcare Platform

    LETTER OF INTENT FOR PROPOSED ACQUISITION OF LEADING HEALTHCARE PLATFORM Transaction Overview Proposed Key Terms Target Established, multi-location musculoskeletal healthcare platform Up to $104M serving patients in multiple states Aggregate purchase price consideration Strategic Fit $30M $10M Compl

  5. Slide 5: Third Quarter & YTD 2026 Financial Highlights

    THIRD QUARTER & YTD 2026 FINANCIAL HIGHLIGHTS Three Months Ended Nine Months Ended 9/30/26 9/30/25 9/30/26 9/30/25 Revenue $1,912,179 $3,058,740 $6,294,016 $8,763,314 Cost of sales $875,420 $1,149,161 $2,756,887 $3,317,943 Gross profit $1,036,759 $1,909,579 $3,537,129 $5,445,371 Gross margin 54.2% 6

  6. Slide 6: Balance Sheet Highlights

    BALANCE SHEET HIGHLIGHTS Accounts Receivable Total Assets $23.4M $30.6M $22.1M $29.1M 12.31.25 9.30.26 12.31.25 9.30.26 5.9% Increase 5.2% Increase 6

  7. Slide 7: Proven Business Model Supports Long-Term Strategy

    PROVEN BUSINESS MODEL SUPPORTS LONG- TERM STRATEGY Proven Economic Model Demonstrated ability to drive growth and profitability in diverse economic markets and conditions Consistent Performance with Limited Working Capital Proven track record of driving return on invested capital Investing in Growth

  8. Slide 8: Q&A

    we 4 CARDIFF LEXINGTON CORPORATION Q&A

  9. Slide 9: Appendix

    we 4 CARDIFF LEXINGTON CORPORATION APPENDIX

  10. Slide 10: Reconciliation of Non-GAAP Metrics

    RECONCILIATION OF NON-GAAP METRICS Three months ended Nine months ended 9/30/26 9/30/25 9/30/26 9/30/25 Net Income (loss) before discontinued operations $(3,206,551) $(1,144,299) $(8,777,531) $(2,821,471) Adjustments to reconcile net income/(loss) to EBITDA Interest 2,468,536 1,765,528 6,516,692 4,5

Cardiff Lexington — Q3 2026 Earnings Presentation on 6ix